Emergency use authorisation (EUA) for Bharat Biotech's Covaxin has been further delayed by the World Health Organisation. According to news agency ANI, the WHO has asked for more data from Bharat Biotech for the COVID-19 vaccine. The development comes after Bharat Biotech had said it has submitted all data required for clearance of Covaxin. Without the EUA, Covaxin will not be considered an accepted vaccine by most countries around the world, making it difficult for Indians who have taken the dose to travel internationally.from IndiaTV India: Google News Feed https://ift.tt/3kMi1mb
Comments
Post a Comment